CM Life Sciences III Inc (CMLTU)

Sector:
FINANCE
Industry:
GENERAL FINANCE
CEO:
Melanie I. Nallicheri
Employees:
240
50 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
6173152266

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

EQRx, Inc. engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor, and Sugemalimab, an anti-programmed death-ligand 1 antibody.

Data derived from most recent annual or quarterly report
Market Cap 354.8 Million Shares Outstanding40 Million Avg 30-day Volume 59.389 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.18
Price to Revenue0.0 Debt to Equity0.0 EBITDA-157.3 Million
Price to Book Value1.6815 Operating Margin0.0 Enterprise Value850.704 Million
Current Ratio24.322 EPS Growth0 Quick Ratio23.929
1 Yr BETA 0.2621 52-week High/Low 11.52 / 8.58 Profit Margin0.0
Operating Cash Flow Growth0.0 Altman Z-Score10.1851 Free Cash Flow to Firm 0

View recent insider trading info

Funds Holding CMLTU (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CMLTU

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GIUSTI KATHRYN E

  • Director
101,010 2022-09-30 1

BERNS PAUL L

  • Director
101,010 2022-09-30 1

MEANWELL CLIVE

  • Director
101,010 2022-09-30 1

MERKSAMER SAMUEL J.

  • Director
101,010 2022-09-30 1

CASDIN ELI

  • Director
  • 10% Owner
101,010 2022-09-30 1

YESHWANT KRISHNA

  • Director
101,010 2022-09-30 1

ABERNETHY AMY

  • Director
101,010 2022-09-30 1

HORNING SANDRA

  • Director
101,010 2022-09-30 1

BORISY ALEXIS

  • Director
0 2021-12-17 0

HEDRICK ERIC CHIEF PHYSICIAN EXECUTIVE

  • Officer
0 2021-12-17 0

CONDE JORGE

  • Director
0 2021-12-17 0

NALLICHERI MELANIE CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2021-12-17 0

RUBIN JAMI CHIEF FINANCIAL OFFICER

  • Officer
0 2021-12-17 0

CMLS HOLDINGS III LLC

C-LSH III LLC

M-LSH III LLC

CASDIN ELI OFFICER (CEO)

MEISTER KEITH A.

  • Officer
  • Director
  • 10% Owner
13,500,000 2021-08-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CM LIFE SCIENCES III INC CMLTU 2021-12-17 22:15:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 21:45:04 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 21:15:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 20:45:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 20:15:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 19:45:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 19:15:04 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 18:45:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 18:15:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 17:45:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 17:15:03 UTC -2.2674 2.3374 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 16:45:02 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 16:15:03 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 15:45:03 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 15:15:03 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 14:45:03 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 14:15:03 UTC -2.173 2.243 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 13:45:03 UTC -2.1589 2.2289 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 13:15:03 UTC -2.1589 2.2289 100000
CM LIFE SCIENCES III INC CMLTU 2021-12-17 12:45:04 UTC -2.1589 2.2289 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments